City of Hope

As City of Hope's new chief operating officer, Angelique Richard, Ph.D., R.N. oversees alignment and innovation across operations at City of Hope National Medical Center, City of Hope Los Angeles, City of Hope Orange County and the cancer center's clinical network in Southern California.   In a new interview with Becker's Healthcare, Dr. Richard talks about leadership, overcoming operational challenges and what’s on the horizon for City of Hope. Read more: https://bit.ly/3SItH9Z

City of Hope and IFLI - Institute for Follicular Lymphoma Innovation announced a $2 million, three-year collaboration to study spontaneous remission in follicular lymphoma, the most common, slow-growing non-Hodgkin's lymphoma. The collaboration aims to understand the tumor microenvironment in patients whose follicular lymphoma goes into remission without any treatment while being monitored over time. Raju K. Pillai, M.D., City of Hope associate clinical professor, Department of Pathology, and director, Pathology Core Laboratories, and Steven T. Rosen, M.D., executive vice president and director emeritus of City of Hope’s comprehensive cancer center and its Beckman Research Institute, professor, Department of Hematology & Hematopoietic Cell Transplantation, and Ted Schwartz Family Distinguished Chair in Hematologic Malignancies, will lead the research. Learn more: https://bit.ly/46yBpcH

Michelle Johann, D.N.P., R.N., loves coming to work every day. As a dedicated clinical practice education specialist and 25-year City of Hope employee, she takes every opportunity to make each patient feel at ease and cherished. During the COVID-19 pandemic, she led the Hope Tours Program at City of Hope, which allowed patients and their families to tour the facilities and meet staff ahead of their scheduled surgeries. This year, Michelle received the Off the Chart award for nursing excellence by the Simms/Mann Institute & Foundation, exemplifying her commitment and profound compassion. “I want [patients] to know that this is your home. You are accepted. You are embraced. You are loved. And you are a priority.” Thank you, Michelle, for helping to create an environment where each patient feels appreciated and valued. Read more about Michelle's dedication and commitment to our patients at City of Hope: https://bit.ly/3Sp1NzO

In addition to being recognized as top 5 in the nation for cancer care, we’re proud to share City of Hope cancer centers across the country were rated “high performing” for cancer procedures and conditions measured by U.S. News & World Report. City of Hope’s campus in Los Angeles was rated as “high performing” for all six cancer procedures and conditions tracked by U.S. News: - Lung cancer surgery - Colon cancer surgery - Prostate cancer surgery - Gynecologic cancer surgery - Gastroenterology and GI cancer surgery - The treatment of leukemia, lymphoma and myeloma. Additionally, City of Hope Atlanta was rated as “high performing” in colon cancer surgery, and City of Hope Chicago was rated as “high performing” in gynecologic cancer surgery. Learn more: https://bit.ly/3LqJshK #BestHospitals

Today, our CEO Robert Stone shared an Open Letter of Hope in The Wall Street Journal and Los Angeles Times highlighting our ranking as top 5 in the nation for cancer care by U.S. News & World Report and thanking our employees, patients, donors and other supporters who are helping make hope a reality for more people. Read the full letter: https://bit.ly/4fokBcq

Congratulations to Prajish Iyer, Ph.D., City of Hope staff scientist, on earning the prestigious Young Investigator Award from Chronic Lymphocytic Leukemia Society (CLL Society) for his research project, "Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation (RT)." The award recognizes early-career scientists committed to advancing the knowledge and treatment of CLL/SLL (small lymphocytic lymphoma). Dr. Iyer explains that although Richter’s Transformation (RT) is rare, it is a devastating event as most patients do not survive more than a year after diagnosis. “The goal of my research, supported by the CLL Society, is to understand the biological processes involved, with the hope that this research will pave the way for new treatment options to effectively target this aggressive form of cancer and bring hope to those battling RT." Dr. Iyer, bravo for your recognition! We admire your courage to study a rare and aggressive condition, your passion for research and making hope a reality for CLL and SLL patients. Read more: https://lnkd.in/eTuNEN4x

City of Hope's team is at the forefront of exciting therapeutic innovations for sarcoma. Three experts explain how sarcoma differs from other cancers, discuss clues that may indicate a person's risk for sarcoma and share advancements in sarcoma treatment. “This is a rare disease best handled by a specialized center,” shares Janet Yoon, M.D., clinical professor and medical director of the Pediatric Musculoskeletal Tumor Program at City of Hope Children’s Cancer Center. “You need an experienced, knowledgeable team. And we at City of Hope have such a team, along with researchers pushing the boundaries.” Read more: https://bit.ly/4f4zoZw

City of Hope employee Mari Uribe-Larios knows the devastating toll cancer can take firsthand: She is a two-time cancer survivor and lost her sister to the disease at 15 years old. Since 2016, Mari has honored her sister and her own story — by participating in our annual Walk for Hope. Together with her family by her side, she’s raised more than $10,000 to fight cancer. Mari, we applaud your commitment to making a difference and can’t wait to see you at this year’s Walk for Hope. Learn more and register today: https://bit.ly/4cFoWpO

We're honored to share insights from City of Hope’s Joanne Jeter, M.D., who is passionate about helping patients manage their genetic risk. Dr. Jeter is committed to providing education on the options available and guiding family members in addressing their own cancer risks. Now a member of its faculty, Dr. Jeter discusses her experience in the Intensive Course and Clinical Cancer Genomics Community of Practice (CCGCoP). Reflecting on her journey through the program at City of Hope, she shares how this transformative program can impact patients and their families.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, is ranked top 5 in the nation for cancer care, according to U.S. News & World Report's 2024-25 rankings. The recognition marks the latest milestone for City of Hope as it enhances its ability to make a meaningful impact on the lives of patients, families and communities nationwide. Learn more: https://bit.ly/3LqJshK #BestHospitals